INTRODUCTION
The chemoprevention of cancer is an urgent priority in the field of public health. It is important that the normal daily diet promotes the prevention of cancer. Our previous studies have illustrated that constituents of herbal medicines can inhibit tumour promotion in a mouse model of two-stage skin carcinogenesis 1) .
In Japan, the leaves of Eucommia ulmoides have been used in tea for the regulation of blood pressure, and the bark of E.
ulmoides is incorporated in herbal medicines used as tonics and anti-hypertensive agents 2) . The chemical constituents of E.
ulmoides reportedly include lignins and iridoids [3] [4] [5] [6] [7] [8] .
In this paper, we demonstrated that the topical application of a methanol extract from Eucommia bark successfully inhibited tumour promotion in a mouse model of two-stage skin carcinogenesis, which was initiated by 7,12-dimethylbenz[a]anthracene (DMBA) and promoted by 12-O-tetradecanoylphorbol-13-acetate (TPA). In our study, methanol extract was suitable for extraction of the active components than water extract 9) . The reason that used methanol is because we expected active component to a low molecular compound. The water extract is suitable for the extraction of the high molecular compound, but is not suitable for the extraction of the low molecular compound.
MATERIALS AND METHODS

Materials
Dried barks and dried leaves of E. ulmoides Oliver were sourced from Kinokuniya Kan-Yaku Kyoku Co., Tokyo, Japan.
Voucher specimens "SM0204" and "SM0205" were deposited at the School of Pharmacy, Nihon University. Louis, Mo., USA. Acetone, chloroform and methanol were obtained from Tokyo Kasei Kogyo Co., Ltd., Japan.
Extraction Procedure
Dried barks (100 g) and dried leaves (100 g) of E. ulmoides were extracted three times for 3 days with methanol (1,000 ml)
at room temperature. The solvents were evaporated in a vacuum to dryness and the extracts were obtained bark extract (dark brown, yield: 7.8 g) and leaf extract (dark green, yield:
8.5 g), respectively. Each extract was examined for inhibitory activity against TPA-induced ear oedema and TPA-induced tumour promotion.
Animals
Experiments were performed in accordance with the Guidelines of the Institutional Animal Care and Use Committee of the School of Pharmacy, Nihon University, Chiba, Japan.
Female ICR mice (SLC Inc., Shizuoka, Japan) were housed in an air-conditioned, specific pathogen-free room (24 ± 2°C) that was lit from 08:00 h to 20:00 h. Food and water were provided ad libitum. 
Statistical analysis
Statistical analysis was performed using Student's t-test and the Mann Whitney U exact test.
RESULTS AND DISCUSSION
Various extracts of the dried barks and leaves of E. ulmoides were tested for their ability to decrease the intensity of TPAinduced ear oedema (Table 1 10) . Therefore, we investigated the inhibitory effects of a methanol extract from Eucommia bark in a mouse model of two-stage skin carcinogenesis, which was initiated using DMBA and promoted using TPA. . Furthermore, syringaresinol and its glucosides showed strong α,α-dipenyl-β-picrylhydrazyl (DPPH) radical-scavenging activity 13, 14) . Free radicals are directly implicated in the development of cancer by their ability to damage the DNA in a cell's nucleus and weaken the immune system, which normally destroys cancer cells or prevents them from reproducing. In the presence of a strong antioxidant defence system, free radicals are neutralized before they can damage DNA; alternatively, the damage can be detected and repaired before progression. Many antioxidants have been associated with a lower risk of cancer. Therefore, it can be assumed that syringaresinol and its glucosides are potential agents for cancer prevention. Moreover, in a previous study, syringaresinol potently inhibited LPS-induced production of NO, PG-E 2 and TNF-α in macrophages. The expression of inducible NO synthase (iNOS) and COX-2 enzyme was also decreased by syringaresinol in a concentration-dependent manner 15) . This is the first study, as per our knowledge, to report that methanol extracts from Eucommia bark inhibited TPA-induced inflammation in mice. Furthermore, these methanol extracts inhibited tumour promotion by TPA following initiation with DMBA. This experiment suggests the potential use of Eucommia bark in cancer prevention. The aim of future investigations should be isolation of the active agent and elucidation of the mechanism by which Eucommia bark exerts its cancer preventive effects. We will examine the dosage dependence of the Eucommia bark. 
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